Tirzepatide (Zepbound) : In the SURMOUNT-4 trial, participants who stopped tirzepatide after losing about 21% of their body weight regained an average of 14% over the following year
The FDA approved saxagliptin, linagliptin, and alogliptin, and the European Union and Japan approved vildagliptin, anagliptin, teneligliptin, trelagliptin, and omarigliptin
GLP-1 receptor agonists have been shown to increase dopamine and serotonin release in the brain, which may contribute to their effects on appetite and satiety
Kind Patches is a wellness company that sells stick-on patches for things like focus, stress, and hormone balance
What to Avoid at Subway on GLP-1 Skip the Meatball Marinara, any sub with extra cheese and creamy sauce, and the footlong versions of heavier items